Steatotic liver disease impacts long-term outcomes after curative-intent surgery for hepatocellular carcinoma
Zeitschrift für Gastroenterologie · 01.09.2024 · 62 (09) · e722
DOI: 10.1055/s-0044-1789899 ↗Kurz gefasst
Fachartikel in der Zeitschrift Zeitschrift für Gastroenterologie, erschienen am 01.09.2024. Verfasst von D. Uluk und 11 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Curative hepatocellular carcinoma (HCC) surgery includes liver resection (LR) and orthotopic liver transplantation (OLT), but outcomes are limited not only by oncological factors, but also by underlying liver disease and impaired overall patient condition. Due to the obesity epidemic, metabolic dysfunction-associated liver disease (MASLD) is becoming a frequent HCC etiology, which can coincide with alcohol-associated (ALD) liver disease, termed MetALD.
Aim
This survey investigates the impact of the MASLD criteria and relevant body composition/BC parameters concerning outcome and survival after curative HCC surgery.
Methods
Patients undergoing LR or OLT for HCC at the Charité Universitätsmedizin Berlin (2010-2020) were included in this study. Disease etiology, oncological and survival data, as well as CT-based BC, were analyzed.
Results
Of 579 patients with HCC, 417 underwent LR and 162 OLT. 191 (33.0%) patients had viral etiology, 158 (27.3%) fulfilled MASLD criteria, 51 (8.8%) had MetALD, 68 (11.7%) had active or former ALD, and 111 (19.2%) had other/cryptogenic HCC etiologies. Patients with MASLD and MetALD had significantly more intramuscular (p
Zitieren
APA
Uluk, D., Herda, S., Pein, J., Bitar, J., Eurich, D., Auer, T. A., Colletini, F., Uluk, Y., Tacke, F., Pratschke, J., Lurje, I., & Lurje, G. (2024). Steatotic liver disease impacts long-term outcomes after curative-intent surgery for hepatocellular carcinoma. Zeitschrift für Gastroenterologie, 62(09), e722. https://doi.org/10.1055/s-0044-1789899
Vancouver
Uluk D, Herda S, Pein J, Bitar J, Eurich D, Auer TA, et al. Steatotic liver disease impacts long-term outcomes after curative-intent surgery for hepatocellular carcinoma. Zeitschrift für Gastroenterologie. 2024;62(09):e722. doi:10.1055/s-0044-1789899
BibTeX
@article{Uluk2024,
author = {Uluk, D. and Herda, S. and Pein, J. and Bitar, J. and Eurich, D. and Auer, T. A. and Colletini, F. and Uluk, Y. and Tacke, F. and Pratschke, J. and Lurje, I. and Lurje, G.},
title = {Steatotic liver disease impacts long-term outcomes after curative-intent surgery for hepatocellular carcinoma},
journal = {Zeitschrift für Gastroenterologie},
year = {2024},
volume = {62},
number = {09},
pages = {e722},
doi = {10.1055/s-0044-1789899}
}
EUVIMED